Delivery Order SPE2DB20D3101-SPE2DB25FRRW6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,349.80 to AmerisourceBergen Drug Corp for WIXELA 500-50 INHUB 60S, a pharmaceutical product, with an ultimate completion date of August 1, 2025. This firm fixed-price, non-set-aside delivery order was awarded on July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $1,610.92, is for the supply of the pharmaceutical product WIXELA 250-50 INHUB 60S. This delivery order is a part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value...
- The Defense Logistics Agency awarded a delivery order valued at $5,948.02 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and was fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $3,142.21 to Amerisourcebergen Drug Corp, a subsidiary of the for-profit company Amerisourcebergen Corporation. The contract is for the delivery of WIXELA 250-50 INHUB 60S pharmaceutical products to support military treatment programs and facilities. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of $999,999,999.00...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,349.05 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of WIXELA 100-50 INHB 60S pharmaceuticals. The contract has a completion date of February 29, 2024 and was awarded on February 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of WIXELA 250-50 INHUB 60S pharmaceuticals. The contract, valued at $1,176.12, has a completion date of March 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,060.22 firm fixed-price delivery order is for the supply of WIXELA 250-50 INHUB 60S, a medical product, with a performance period ending on April 30, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This delivery order, valued at $1,373.64, was awarded to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Wixela 500-50 Inhub 60s pharmaceutical product. The contract, issued by the Defense Logistics Agency (DLA), carries a firm fixed price structure with no set-aside designation and is scheduled for completion by August 1, 2025. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This award represents a child contract under...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WIXELA 500-50 INHUB 60S medication. The contract has a ceiling value of $1,339.08 and a period of performance through May 1, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,042.24, is for the delivery of WIXELA 250-50 INHUB 60S medical products. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRRW6Delivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,231.35 for WIXELA 250-50 INHUB 60S, a pharmaceutical product, with a completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child task order under AmerisourceBergen Drug Corp's larger contract vehicle with the DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the primary vehicle enabling the company to supply pharmaceutical products and medical supplies to military healthcare systems globally. This delivery order for WIXELA is representative of the company's extensive portfolio of federal medical procurement, which includes brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company serves critical federal healthcare customers including the Defense Health Agency and the U.S. Coast Guard through its comprehensive pharmaceutical support programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/5/25 |